Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Nolan Townsend, CEO of LEXEO Therapeutics
What you'll get out of this episode:
- Can you tell us about your background and what led you to LEXEO?
- What product candidates are development at LEXEO?
- How is what LEXEO is developing different than the current treatments in the neurological and cardiac spaces?
- At BIO you spoke to the topic of accelerated approval, can you provide some perspective on the pathways needed for accelerated approval in gene therapy?
- How does gene therapy address patient needs across disease areas?
- What's next?
Full Video and more info click here: Slice Of Healthcare Website
Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/
FlipMD by GoodRX https://www.goodrx.com/
Quantum Health https://quantum-health.com/
To learn more about LEXEO Therapeutics please use the links below:
- LEXEO TX LinkedIN - LEXEO TX Website -